Forms of respiratory diseasesThe future of respiratory diseases Until recently, COVID-19 seemed to be a harmless pathogen of minor outbreaks of unremarkable and mild acute respiratory diseases. At the same time, many similar microorganisms lived in natural reservoirs - in the body of exotic Asian animals.
More than 200 million respiratory tract infections occur each year globally . Only less than a third of them go through health workers, primarily with the outpatient network, which accounts for more than 10% of all visits to the office of a primary care doctor. The problem of high morbidity and significant economic losses increases significantly due to complications, which can often end in death. Pneumonia and influenza together are the fourth leading cause of death in people aged 65 and over.
Given the similarity of the symptoms of respiratory infections, it is very important for adequate therapy to timely separate COVID-19 and seasonal SARS and influenza, as well as bacterial pathology. Next, doctors struggle with the syndromes caused by the disease. Treatment may require anti-inflammatory therapy, therapy aimed at eliminating coagulation disorders, and, finally, therapy aimed at correcting hypoxemia or respiratory failure. Of course, each patient may have their own unique features over the course of the disease, so the therapy in each case will be different.
The emergence of pulmonary fibrosis Fibrosis is the body's defense response to inflammation or injury. It occurs in approximately 10-15% of patients who recover from viral pneumonia associated with COVID-19.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: medical_xpress - 🏆 101. / 51 Read more »